SCHEMBL32673552

SCHEMBL32673552

Cc1ccccc1-n1c(C(=O)O)cc2ccccc2c1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.54
LMNA P02545 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
NOTUM Q6P988 1/20 0.48
PDE10A Q9Y233 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
MAPT P10636 2/20 0.45
TP53 P04637 2/20 0.45
GAA P10253 1/20 0.44
PKM P14618 1/20 0.44
HTT P42858 1/20 0.44
TSHR P16473 1/20 0.44
PDE7A Q13946 1/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
PDE4D Q08499 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HPD P32754 2/20 0.42
MCL1 Q07820 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28305236 0.84 NOTUM (0.47) ALDH1A1LMNAL3MBTL1NOTUMPDE10A
SCHEMBL27804105 0.81 ALDH1A1 (0.64) ALDH1A1NOTUMGAATSHRKDM4E
SCHEMBL28113666 0.80 ALDH1A1 (0.56) ALDH1A1LMNAL3MBTL1NOTUMSMN1; SMN2
SCHEMBL28274744 0.75 ALDH1A1 (0.51) ALDH1A1LMNAL3MBTL1SMN1; SMN2MAPT
SCHEMBL3282509 0.75 MCL1 (0.62) ALDH1A1SMN1; SMN2MAPTGAAPKM
SCHEMBL31371682 0.75 MCL1 (0.62) ALDH1A1SMN1; SMN2MAPTGAAPKM
SCHEMBL1718161 0.74 ALDH1A1 (0.52) ALDH1A1LMNAL3MBTL1NOTUMPDE10A
SCHEMBL5030756 0.73 DAO (0.61) ALDH1A1LMNASMN1; SMN2MAPTGAA
SCHEMBL1202364 0.73 KMT2A (0.48) ALDH1A1LMNASMN1; SMN2MAPTGAA
SCHEMBL5021829 0.72 KDM4E (0.62) ALDH1A1LMNAL3MBTL1NOTUMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260042780-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS INTELLIKINE LLC (US) 2026-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042780-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS PTEN, PIK3C2A, PIK3CA ALDH1A1 3910/4885LMNA 952/4885L3MBTL1 3878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.